DAWN MACKE: Open Payments
NPI 1336512672 · SIDNEY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,907 in 116 payments from 20 companies in 2025. Trend: 2023 $633 · 2024 $1,430 · 2025 $1,907
Food & beverage: $1,907
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $386 |
| AstraZeneca Pharmaceuticals LP | 16 | $374 |
| Otsuka America Pharmaceutical, Inc. | 12 | $207 |
| Novo Nordisk Inc | 14 | $161 |
| Lilly USA, LLC | 13 | $157 |
| Vanda Pharmaceuticals Inc. | 3 | $75 |
| Lundbeck LLC | 3 | $65 |
| Alkermes, Inc. | 3 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $57 |
| PFIZER INC. | 3 | $54 |
Products named: VRAYLAR, REXULTI, ANDEXXA, MOUNJARO, AIRSUPRA, Wegovy, FARXIGA, UBRELVY.
Industry payments across OH — which companies pay providers there.
